Published in Am J Gastroenterol on February 22, 2011
Postoperative Opioid Use and Ileus Occurrence---A Case Control Study | NCT05262569
Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil (2014) 1.19
Opiate-induced constipation related to activation of small intestine opioid μ2-receptors. World J Gastroenterol (2012) 1.06
The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability. ACS Chem Neurosci (2012) 0.94
Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis. Drug Des Devel Ther (2015) 0.91
Opioid-induced bowel dysfunction. Curr Gastroenterol Rep (2013) 0.90
Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation. Pain Med (2015) 0.89
Pain Intensity Recognition Rates via Biopotential Feature Patterns with Support Vector Machines. PLoS One (2015) 0.88
Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone. Clin Drug Investig (2015) 0.88
Population pharmacokinetics of naloxegol in a population of 1247 healthy subjects and patients. Br J Clin Pharmacol (2015) 0.87
Site and mechanism of morphine tolerance in the gastrointestinal tract. Neurogastroenterol Motil (2014) 0.86
Pharmacological agents currently in clinical trials for disorders in neurogastroenterology. J Clin Invest (2013) 0.83
Prevalence and types of rectal douches used for anal intercourse: results from an international survey. BMC Infect Dis (2014) 0.83
A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain. Pain Med (2014) 0.83
Irritable bowel syndrome: how useful is the term and the 'diagnosis'? Therap Adv Gastroenterol (2012) 0.83
Chronic methadone use, poor bowel visualization and failed colonoscopy: a preliminary study. World J Gastroenterol (2012) 0.81
The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activity. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.81
Opioid-induced mitogen-activated protein kinase signaling in rat enteric neurons following chronic morphine treatment. PLoS One (2014) 0.79
Evolving paradigms in the treatment of opioid-induced bowel dysfunction. Therap Adv Gastroenterol (2015) 0.79
Absorption, distribution, metabolism, and excretion of [14C]-labeled naloxegol in healthy subjects. Int J Clin Pharmacol Ther (2015) 0.79
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments. Front Pharmacol (2016) 0.78
Pain care for patients with epidermolysis bullosa: best care practice guidelines. BMC Med (2014) 0.77
New treatment options for chronic constipation: mechanisms, efficacy and safety. Can J Gastroenterol (2011) 0.77
Neurochemical phenotype and function of endomorphin 2-immunopositive neurons in the myenteric plexus of the rat colon. Front Neuroanat (2014) 0.76
Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation. J Pharmacol Pharmacother (2015) 0.76
Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice. Int J Gen Med (2016) 0.76
The impact of opiate pain medications and psychoactive drugs on the quality of colon preparation in outpatient colonoscopy. Dig Liver Dis (2013) 0.75
Opioid and chronic non-cancer pain. J Anaesthesiol Clin Pharmacol (2013) 0.75
Opioid-induced Lower Esophageal Sphincter Dysfunction. J Neurogastroenterol Motil (2015) 0.75
Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy-tolerability pilot study. Neuropsychiatr Dis Treat (2016) 0.75
Tramadol/Paracetamol fixed-dose combination for chronic pain management in family practice: a clinical review. ISRN Family Med (2013) 0.75
Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trial. BMC Gastroenterol (2013) 0.75
Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults. World J Clin Cases (2017) 0.75
Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis. Onco Targets Ther (2016) 0.75
6β-N-Heterocyclic Substituted Naltrexamine Derivative BNAP: A Peripherally Selective Mixed MOR/KOR Ligand. ACS Chem Neurosci (2016) 0.75
Interventions That Affect Gastrointestinal Motility in Hospitalized Adult Patients: A Systematic Review and Meta-Analysis of Double-Blind Placebo-Controlled Randomized Trials. Medicine (Baltimore) (2016) 0.75
Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility. Adv Ther (2016) 0.75
Modeling the Frequency and Costs Associated with Postsurgical Gastrointestinal Adverse Events for Tapentadol IR versus Oxycodone IR. Am Health Drug Benefits (2013) 0.75
Re: opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol (2011) 0.75
Developments in managing severe chronic pain: role of oxycodone-naloxone extended release. Drug Des Devel Ther (2015) 0.75
Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation. Drugs Aging (2016) 0.75
An Ecological Study of the Association between Opiate Use and Incidence of Cancers. Addict Health (2016) 0.75
Pre-operative opioid analgesia reduces clinical success of laparoscopic gastric electrical stimulation placement in patients with gastroparesis. Surg Endosc (2014) 0.75